Perelel has acquired LOOM, an educational platform for reproductive health, sexual wellness and parenting. Through the acquisition, the company aims to advance health literacy for women.
Novant Health called off its planned $320 million acquisition of two CHS-owned hospitals in North Carolina. The decision came after an appellate court granted the FTC an emergency injunction to block the deal — the agency had been challenging the deal for more than a year.
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.
Knownwell acquired one of its competitors, just six months after announcing its $20 million Series A funding round. The startup, which provides hybrid primary care and metabolic health treatment, bought Alfie Health, an online obesity management clinic with an AI platform that generates personalized recommendations for weight management.
Centivo, a health plan that sells to self-funded employers, acquired virtual-first primary care startup Eden Health. With this acquisition, Centivo now serves more than 160 employers in all 50 states.
Novo Holdings’ $16.5 billion planned acquisition of Catalent is facing another delay. Just weeks after Novo decided to resubmit its application to the FTC, the agency is seeking more information about the deal. This move has triggered a second 30-day delay in the antitrust review process.
WebMD acquired the operating assets of Healthwise, a nonprofit provider of health education content and patient engagement tools. The deal follows another acquisition WebMD made in the patient engagement space in 2020. According to Ann Bilyew, WebMD’s senior vice president of health, the company is now “the indisputable market leader in providing patient education to both providers and payers.”
Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.
General Catalyst just announced its plans to acquire Summa Health, an Ohio-based health system. Leaders from across the healthcare industry aren't sure how the deal will play out, given the novel nature of the deal and the involvement of one of the country’s most prominent VC firms.
Innovaccer acquired Cured, a healthcare digital marketing and CRM platform. With the deal, Innovaccer gains more than 20 customers to add to its current portfolio of clients. Innovaccer CEO Abhinav Shashank said the main goal of the acquisition was to help his company become a leader in patient experience technology.
Guidehealth, a nascent value-based care enablement startup, acquired Arcadia’s value-based care service division. Acquiring this business unit allows Guidehealth to provide health systems with a platform that helps them succeed in value-based care arrangements while still maintaining their patient volume levels.
AbbVie announced plans to acquire Immunogen — and the biotech’s recently approved ADC treatment for ovarian cancer — for $10.1 billion in cash. The pharma giant is diving into ADCs again after a previous multibillion-dollar acquisition of a different ADC drugmaker ended up failing a few years ago.
Executives from Imagine360, Verily, BrightInsight, Lantern, and Rhapsody shared their approaches to reducing healthcare costs and facilitating digital transformation.
Acquiring Point Biopharma gives Eli Lilly a pipeline of radiopharmaceuticals, including one for prostate cancer that could rival Novartis’s Pluvicto. The deal comes ahead of an expected Phase 3 data readout for that Point therapeutic candidate.
This week, Abbott announced its plans to acquire Bigfoot Biomedical — a startup selling a “smart” insulin pen cap, which collects data from a user’s CGM to help them calculate the right dose. Most analysts were unsurprised to hear of the acquisition given that the two companies have been collaborating for more than six years, but they said the deal reinforces the steady pace of digital innovation in the diabetes care space.
Bright Health Group said last week it is “exploring strategic alternatives” for two Medicare Advantage plans in California: Brand New Day and Central Health Plan, which the insurtech purchased several years ago for $500 million. One expert said selling is necessary as the company faces bankruptcy.
WeightWatchers will acquire Sequence, a platform that allows patients to have virtual appointments with a clinician, gives access to a dietitian and fitness coaching and provides prescription medications, including Ozempic and Wegovy. The deal is anticipated to close during the second quarter of 2023, and WeightWatchers will pay the net purchase price of $106 million.
London-based Unmind offers a measurement tool that allows employees to gain insights into their own mental health. Its content library also provides access to exercises and self-guided courses. Dublin-based Frankie Health, meanwhile, connects employees to a global network of mental health practitioners. The combined organization's new product, Unmind Talk, joins the strengths of both companies.